Jose G. Merino, MD, MPhil


June 11, 2014

In This Article

Movement, Microglia, and the Stroke Epidemic

Functional Imaging in Movement Disorders

The role of imaging biomarkers to study neurodegenerative and movement disorders was the focus of the talk[6] by David Eidelberg, MD, Investigator and Head of the Susan and Leonard Feinstein Center for Neurosciences at North Shore-LIJ Health System. His research focuses on the use of functional imaging and spatial covariance analysis to detect abnormal functional networks in neurologic diseases.

Using fludeoxyglucose PET, Dr. Eidelberg and his colleagues looked for specific patterns of glucose utilization associated with specific neurologic conditions.[7] In a study of 167 patients, for example, they found that metabolic brain imaging could accurately discriminate patients with Parkinson disease, multiple system atrophy, and progressive supranuclear palsy 3 years before a definitive clinical diagnosis was made.[8] The findings have been replicated by other investigators.[9]

These results suggest that functional imaging and spatial covariance analysis can identify patients with specific parkinsonian syndromes early, leading to timely discussions about prognosis and treatment. These findings also have implications for optimizing clinical trial design, because functional imaging can ensure that trials enroll patients with the target disease, even in the early stages, and can be used to understand the factors that affect the placebo response.

Microglial Signatures in Health and Disease

Microglia are myeloid cells that are important for normal central nervous system (CNS) function. They are also involved in several disease states in which immune processes play a role, such as ALS, multiple sclerosis, and even Alzheimer disease.[10] Differentiating microglia from peripheral monocytes or other CNS cells (oligodendrocytes, astrocytes, and neurons) is necessary to study how these cells contribute to pathologic processes.

Oleg Butovsky, PhD, from Brigham and Women's Hospital and Harvard Medical School gave an excellent talk[11] about his work using gene and microRNA array analyses and quantitative proteomic analyses to identify a genetic and molecular microglial signature that is dependent on transforming growth factor-beta signaling in rodents and humans.[2] These findings are an important step in developing transgenic animal models that allow the study of the role of microglia in disease states.

Dr. Butovsky has developed mouse models to study microglia integrity and activity in ALS and experimental autoimmune encephalomyelitis. These models will lead to identification of therapeutic targets, and monoclonal antibodies that target microglia.

The Worldwide Stroke Epidemic

According to Jerome Chin, MD, PhD, MPH,[12] lecturer in global health at the University of California, Berkeley, vascular disease is the major threat to the long-term survival of humans as a species, even more so than global warming and nuclear war. Almost one quarter of deaths worldwide are the result of ischemic heart disease and stroke, and the problem is getting worse because the stroke and heart attack rates are highest in low- and middle-income countries, where most of the world population resides.

Several factors are to blame: poor access to care; an aging world population; urbanization (more than one half of the world's population now lives in cities) that leads to a sedentary lifestyle and access to processed foods; increasing obesity rates; and a high prevalence of smoking (in China, 45% of men smoke, and in Russia, 55% do). Moreover, between 25% and 50% of adults worldwide have hypertension, and most are untreated.

Dr. Chin reminded us that governments need policies and actions to stem the stroke epidemic. Public health measures that promote healthy diets and physical activity, and access to high-quality and affordable primary care, are a cornerstone of such policies. Many countries, however, do not have sufficient resources to address these issues alone.

The international medical community can help translate advances in prevention science into public action, collaborating with governments and civil societies. Dr. Chin described a successful example of an organization that engages international physicians and local communities: the Alliance for Stroke Awareness and Prevention Project in Uganda. Over the past few years, this organization has screened more than 50,000 people for hypertension and worked with the local health system to promote treatment. The organization is expanding into India and other countries.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: